Padup Ventures
609, Star Tower, adjacent to Star Mall on NH8, Exit 8, Block A, Sector 30, Gurugram, Haryana, 122022, India
Overview
Padup Ventures program to Validate, Incubate & Accelerate enables entrepreneurs transform through a deep, well-designed and structured education, mentoring and monitoring process by mentors who have been there and done that.
- Total investments
- 3
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 3
Investment portfolio
- Dectrocel
Participated · Equity · Sep 2025
Dectrocel develops AI-powered diagnostic tools, with flagship product DecXpert delivering chest X-ray and CT-scan interpretations and claiming 10x faster results with 98% accuracy. DecXpert is one of only three AI-based diagnostic tools approved for clinical use in India by the CDSCO and reports a 40.1% improvement in missed case detection validated in Nature Scientific. The company targets diagnostic gaps caused by India’s acute radiologist shortage (reported 1:125,000), particularly in tier-2 and smaller cities where delays and errors are common. Dectrocel plans to scale commercial deployment across OEM partner networks, penetrate India’s digital X-ray market, and establish an initial presence in Southeast Asia. It is also developing new diagnostic modules for CT/MRI/PET-CT and HPB disease detection and enhancing its self-learning multimodal AI capabilities. The company raised Rs 4 crore in the reported funding round to support these plans.
- IntelleWings
Participated · Series A · Apr 2022
IntelleWings builds AI-powered, SaaS-enabled AML/CFT (anti-money-laundering and customer screening) solutions for financial institutions and DNFBPs. The company positions itself as a RegTech provider with a dedicated business research division to keep its products updated. IntelleWings counts one of India’s largest private sector banks and 10 DNFBP clients in the Middle East among its customers, and serves clients in India and the UAE. Headquartered in India, the company plans to expand into new markets including the US. In March 2022 IntelleWings raised $650,000 in a pre-Series A round to support business development and hiring senior leadership. The team emphasizes introducing game-changing solutions and products driven by experienced business and technology professionals.
- Amelioratebiotech
Participated · Equity · Jul 2020
Ameliorate Biotech is a PadUp mentee developing ASSURED, a device for rapid detection of malaria, chikungunya and dengue. ASSURED is designed to provide early detection of these mosquito-borne illnesses and support public-health efforts. CEO and co-founder Dr Rashbehari Tunga said the product will contribute immensely to the nation’s fight against these diseases by enabling early detection. The company raised Rs 2 Cr in angel funding to support its work. The funds will be used to conclude clinical trials efficiently and to pursue subsequent commercialisation of the kits.